Literature DB >> 21960801

Is mesalamine safe?

Kenneth W Schroeder1.   

Abstract

Entities:  

Year:  2007        PMID: 21960801      PMCID: PMC3104151     

Source DB:  PubMed          Journal:  Gastroenterol Hepatol (N Y)        ISSN: 1554-7914


× No keyword cloud information.
  20 in total

Review 1.  Oral 5-aminosalicylic acid for maintenance of remission in ulcerative colitis.

Authors:  L Sutherland; J K Macdonald
Journal:  Cochrane Database Syst Rev       Date:  2006-04-19

2.  Sulphasalazine and salicylazosulphadimidine in ulcerative colitis.

Authors:  J H BARON; A M CONNELL; J E LENNARD-JONES; F A JONES
Journal:  Lancet       Date:  1962-05-26       Impact factor: 79.321

3.  Lung disease associated with orally administered mesalamine for ulcerative colitis.

Authors:  M A Reinoso; K W Schroeder; R J Pisani
Journal:  Chest       Date:  1992-05       Impact factor: 9.410

Review 4.  Conventional therapy for Crohn's disease.

Authors:  Carsten Büning; Herbert Lochs
Journal:  World J Gastroenterol       Date:  2006-08-14       Impact factor: 5.742

5.  Lack of cross-reactivity between 5-aminosalicylic acid-based drugs: a case report and review of the literature.

Authors:  Shiang-Ju Kung; Cuckoo Choudhary; Stephen J McGeady; John R Cohn
Journal:  Ann Allergy Asthma Immunol       Date:  2006-09       Impact factor: 6.347

Review 6.  Can a drug-induced pulmonary hypersensitivity reaction be dose-dependent? A case with mesalamine.

Authors:  P Sossai; M G Cappellato; S Stefani
Journal:  Mt Sinai J Med       Date:  2001-11

7.  Adverse reactions during salicylazosulfapyridine therapy and the relation with drug metabolism and acetylator phenotype.

Authors:  K M Das; M A Eastwood; J P McManus; W Sircus
Journal:  N Engl J Med       Date:  1973-09-06       Impact factor: 91.245

Review 8.  Oral 5-aminosalicylic acid for induction of remission in ulcerative colitis.

Authors:  L Sutherland; J K MacDonald
Journal:  Cochrane Database Syst Rev       Date:  2003

9.  Sulfasalazine: II. Some notes on the discovery and development of salazopyrin.

Authors:  N Svartz
Journal:  Am J Gastroenterol       Date:  1988-05       Impact factor: 10.864

Review 10.  Mesalamine-induced lung toxicity.

Authors:  A Bitton; M A Peppercorn; J P Hanrahan; M P Upton
Journal:  Am J Gastroenterol       Date:  1996-05       Impact factor: 10.864

View more
  7 in total

Review 1.  A Comprehensive Review of the Diagnosis and Pharmacological Management of Crohn's Disease in the Elderly Population.

Authors:  David Kim; Sasha Taleban
Journal:  Drugs Aging       Date:  2019-07       Impact factor: 3.923

2.  Isolated fever induced by mesalamine treatment.

Authors:  Rita Slim; Joseph Amara; Roy Nasnas; Khalil Honein; Joseph Bou Jaoude; Cesar Yaghi; Fady Daniel; Raymond Sayegh
Journal:  World J Gastroenterol       Date:  2013-02-21       Impact factor: 5.742

3.  Ulcerative colitis flair induced by mesalamine suppositories hypersensitivity.

Authors:  Hao Ding; Xiao-Chang Liu; Qiao Mei; Jian-Ming Xu; Xiang-Yang Hu; Jing Hu
Journal:  World J Gastroenterol       Date:  2014-04-07       Impact factor: 5.742

Review 4.  Five-aminosalicylic Acid: an update for the reappraisal of an old drug.

Authors:  Cristiana Perrotta; Paolo Pellegrino; Eliana Moroni; Clara De Palma; Davide Cervia; Piergiorgio Danelli; Emilio Clementi
Journal:  Gastroenterol Res Pract       Date:  2015-01-21       Impact factor: 2.260

Review 5.  Optimal Endpoint of Therapy in IBD: An Update on Factors Determining a Successful Drug Withdrawal.

Authors:  Anita Annaházi; Tamás Molnár
Journal:  Gastroenterol Res Pract       Date:  2015-06-14       Impact factor: 2.260

6.  ZnO nanoparticles act as supportive therapy in DSS-induced ulcerative colitis in mice by maintaining gut homeostasis and activating Nrf2 signaling.

Authors:  Jinquan Li; Hanqing Chen; Bing Wang; Chengxu Cai; Xu Yang; Zhifang Chai; Weiyue Feng
Journal:  Sci Rep       Date:  2017-02-24       Impact factor: 4.379

Review 7.  Long-term efficacy and safety of once-daily mesalazine granules for the treatment of active ulcerative colitis.

Authors:  Stephan Karl Böhm; Wolfgang Kruis
Journal:  Clin Exp Gastroenterol       Date:  2014-09-23
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.